Showing results (591-600 of 3,371) with videos related to
Sort By:
Pageof 338
Applied Microbiology|March 1, 1973
Identification of Staphylococcus aureus by simultaneous use of tube coagulase and thermonuclease testsA L Barry, R V Lachica, F W AtchisonDiagnostic Microbiology and Infectious Disease|January 1, 1987
Bactericidal activities of ten different fluoroquinolones against selected EnterobacteriaceaeA L Barry, R V Gardiner, R R PackerBurns : Journal of the International Society for Burn Injuries|June 10, 2009
Intra-alveolar IL-6 levels following burn and inhalation injuryP C Fuchs, E Demir, K Reuber, et al.Annals of Burns and Fire Disasters|May 31, 2021
Our Initial Experience In The Customized Treatment Of Donor Site And Burn Wounds With A New Nanofibrous Temporary Epidermal LayerA Schulz, P C Fuchs, W Heitzmann, et al.Chirurgie (Heidelberg, Germany)|December 15, 2021
[The medical habilitation at German universities: a comparison of the regulations over 23 years]H Sorg, J Ehlers, M Bagheri, et al.The Journal of Hospital Infection|September 1, 1999
A new technique for quantitative bacterial assessment on burn wounds by modified dermabrasionN Pallua, P C Fuchs, B Hafemann, et al.Journal of Clinical Microbiology|April 1, 1982
In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compoundsR N Jones, H W Wilson, W J NovickDiagnostic Microbiology and Infectious Disease|February 12, 1998
Avoparcin, a glycopeptide used in animal foods: antimicrobial spectrum and potency tested against human isolates from the United StatesM G Cormican, M E Erwin, R N JonesDiagnostic Microbiology and Infectious Disease|February 12, 1998
In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sampleM A Pfaller, S A Marshall, R N JonesClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 10, 2004
Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylaseT R Fritsche, G J Moet, R N JonesPageof 338